Early Medical Lead, Specialty Medicine
GSK plc
About this role
A Senior Medical Affairs leader for Global Specialty Care Early Assets who provides strategic medical direction across a portfolio of early-stage medicines and vaccines to support portfolio progression and evidence planning. The role partners with R&D and commercial stakeholders to shape integrated evidence and commercialization strategies and to ensure assets are prepared for launch and post-approval evidence generation. It supports decision-making at key development gates and helps translate medical insights into portfolio positioning.
Skills
Qualifications
About GSK plc
gsk.comAt GSK, we unite science, technology and talent to get ahead of disease together
Recent company news
GSKGSK enters agreement to acquire 35Pharma Inc.
2 weeks ago
MarketBeatGSK PLC Sponsored ADR $GSK Shares Sold by Quantbot Technologies LP
5 days ago
TipRanksGSK Adds Elizabeth McKee Anderson to Corporate Responsibility Committee
2 days ago
GSKGSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
GSKGSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years
Sep 17, 2025
About GSK plc
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for GSK plc.
Salary
$139k – $188k
per year
More jobs at GSK plc
Similar Jobs
Senior Director, Head of Early Development Regulatory Affairs
Revolution Medicines
6-month internship - global vaccines public affairs
Sanofi
Associate Project Manager - Medical Affairs
Sanofi
Student Worker, Medical Affairs Strategy
Genmab
China Development Team Leader
Bristol Myers Squibb
Director, New Product Commercialization
Neurocrine Biosciences